Chemomab Therapeutics Ltd DRC (CMMB) — Financial Flexibility Index
Chemomab Therapeutics Ltd DRC (CMMB) has a Financial Flexibility Index of -7.59x as of December 2025. Free cash flow of $-11.22 Million (operating CF $-11.22 Million minus capex $3.03K) represents -8% of total liabilities ($1.48 Million). Check Chemomab Therapeutics Ltd DRC (CMMB) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chemomab Therapeutics Ltd DRC Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Chemomab Therapeutics Ltd DRC across 11 annual periods. See Chemomab Therapeutics Ltd DRC (CMMB) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chemomab Therapeutics Ltd DRC (2015–2025)
Year-by-year free cash flow to debt coverage for Chemomab Therapeutics Ltd DRC. For the full company profile including market capitalisation, see how much is Chemomab Therapeutics Ltd DRC worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.59x | $-11.22 Million | $-11.22 Million | $1.48 Million | ▼ -68.2% |
| 2024 | -4.51x | $-15.46 Million | $-15.46 Million | $3.43 Million | ▲ +1.3% |
| 2023 | -4.57x | $-23.55 Million | $-23.55 Million | $5.15 Million | ▼ -54.5% |
| 2022 | -2.96x | $-20.22 Million | $-20.29 Million | $6.84 Million | ▲ +29.7% |
| 2021 | -4.21x | $-12.14 Million | $-12.38 Million | $2.89 Million | ▲ +44.8% |
| 2020 | -7.63x | $-12.77 Million | $-12.80 Million | $1.67 Million | ▼ -125.1% |
| 2019 | -3.39x | $-16.42 Million | $-16.51 Million | $4.85 Million | ▲ +28.3% |
| 2018 | -4.72x | $-13.96 Million | $-14.18 Million | $2.96 Million | ▼ -49.0% |
| 2017 | -3.17x | $-8.55 Million | $-8.58 Million | $2.70 Million | ▼ -104.1% |
| 2016 | -1.55x | $-3.66 Million | $-3.74 Million | $2.36 Million | ▲ +70.8% |
| 2015 | -5.32x | $-7.29 Million | $-7.38 Million | $1.37 Million | — |